Ocugen, Inc. – Pursuing Innovative Ocular Biotherapeutics

COVAXIN News

May 13, 2021

Marshall Plan meets Moonshot: Make the US humanity’s Covid medicine cabinet

May 3, 2021

Ocugen shares continue to ride COVID wave as Bharat data hints vaccine protects against variant

May 3, 2021

Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2

Press Releases

May 7, 2021

Ocugen Provides Business Update and First Quarter 2021 Financial Results

May 6, 2021

Ocugen Presents New Preclinical OCU200 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

May 3, 2021

Ocugen to Host Conference Call on Friday, May 7 at 8:30 a.m. ET to Discuss First Quarter 2021 Financial Results and Provide Business Update

Sign up to receive email alerts with the latest news from Ocugen Subscribe